TNDM Stock Surges 2.26% as Tandem Diabetes Tests Key $20 Resistance
Tandem Diabetes Care (TNDM) rallied 2.26% as the stock tests key resistance near $20. Technical analysis suggests a potential breakout, but confirmation is needed.
AI
2026-08-02
2 阅读
Zyra